Shanxi C&Y Pharmaceutical Group Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.092x

Shanxi C&Y Pharmaceutical Group Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shanxi C&Y Pharmaceutical Group Co Ltd (300254) has a cash flow conversion efficiency ratio of 0.092x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥52.93 Million ≈ $7.75 Million USD) by net assets (CN¥577.09 Million ≈ $84.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shanxi C&Y Pharmaceutical Group Co Ltd (2008–2025)

Cash flow conversion efficiency of Shanxi C&Y Pharmaceutical Group Co Ltd from 2008 to 2025. This chart illustrates how Shanxi C&Y Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shanxi C&Y Pharmaceutical Group Co Ltd (300254) share price today for real-time trading data and today's change.

Shanxi C&Y Pharmaceutical Group Co Ltd Cash Flow Conversion Ratio Explained

Shanxi C&Y Pharmaceutical Group Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shanxi C&Y Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanxi C&Y Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Also see market cap of Shanxi C&Y Pharmaceutical Group Co Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Marshall Boya ve Vernik Sanayi AS IS:MRSHL	-0.140x
Hangzhou Todaytec Digital Co Ltd Class A SHE:300743	0.067x
Chongqing New Dazheng Property Grp SHE:002968	0.029x
Ainsworth Game Technology Ltd AU:AGI	-0.017x
Hubei Forbon Technology Co Ltd SHE:300387	0.007x
Sight Sciences Inc NASDAQ:SGHT	-0.136x
Zhejiang Canaan Technology Co Ltd SHE:300412	0.075x
Vátryggingafélag Íslands hf IC:SKAGI	0.083x

Annual Cash Flow Conversion Efficiency for Shanxi C&Y Pharmaceutical Group Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Shanxi C&Y Pharmaceutical Group Co Ltd from 2008 to 2025. Review Shanxi C&Y Pharmaceutical Group Co Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥594.33 Million ≈ $86.97 Million	CN¥96.77 Million ≈ $14.16 Million	0.163x	+37.29%
2024-12-31	CN¥598.18 Million ≈ $87.53 Million	CN¥70.94 Million ≈ $10.38 Million	0.119x	+144.13%
2023-12-31	CN¥778.43 Million ≈ $113.91 Million	CN¥37.81 Million ≈ $5.53 Million	0.049x	-52.66%
2022-12-31	CN¥729.68 Million ≈ $106.78 Million	CN¥74.88 Million ≈ $10.96 Million	0.103x	-21.17%
2021-12-31	CN¥744.58 Million ≈ $108.96 Million	CN¥96.92 Million ≈ $14.18 Million	0.130x	+644.07%
2020-12-31	CN¥872.61 Million ≈ $127.69 Million	CN¥-20.88 Million ≈ $-3.05 Million	-0.024x	-132.04%
2019-12-31	CN¥932.60 Million ≈ $136.47 Million	CN¥69.63 Million ≈ $10.19 Million	0.075x	+80.88%
2018-12-31	CN¥931.24 Million ≈ $136.27 Million	CN¥38.44 Million ≈ $5.63 Million	0.041x	-0.04%
2017-12-31	CN¥971.17 Million ≈ $142.11 Million	CN¥40.10 Million ≈ $5.87 Million	0.041x	-5.33%
2016-12-31	CN¥954.85 Million ≈ $139.72 Million	CN¥41.65 Million ≈ $6.09 Million	0.044x	+146.44%
2015-12-31	CN¥872.50 Million ≈ $127.67 Million	CN¥15.44 Million ≈ $2.26 Million	0.018x	-82.27%
2014-12-31	CN¥823.16 Million ≈ $120.45 Million	CN¥82.19 Million ≈ $12.03 Million	0.100x	-4.94%
2013-12-31	CN¥767.16 Million ≈ $112.26 Million	CN¥80.58 Million ≈ $11.79 Million	0.105x	+95.14%
2012-12-31	CN¥651.17 Million ≈ $95.29 Million	CN¥35.05 Million ≈ $5.13 Million	0.054x	+558.60%
2011-12-31	CN¥581.17 Million ≈ $85.04 Million	CN¥4.75 Million ≈ $695.08K	0.008x	-97.65%
2010-12-31	CN¥149.59 Million ≈ $21.89 Million	CN¥52.03 Million ≈ $7.61 Million	0.348x	-61.24%
2009-12-31	CN¥117.60 Million ≈ $17.21 Million	CN¥105.55 Million ≈ $15.45 Million	0.898x	+344.54%
2008-12-31	CN¥106.70 Million ≈ $15.61 Million	CN¥-39.16 Million ≈ $-5.73 Million	-0.367x	--

About Shanxi C&Y Pharmaceutical Group Co Ltd

SHE:300254 China Drug Manufacturers - Specialty & Generic

Market Cap

$283.41 Million

CN¥1.94 Billion CNY

Market Cap Rank

#14833 Global

#4355 in China

Share Price

CN¥7.53

Change (1 day)

+2.59%

52-Week Range

CN¥7.27 - CN¥14.68

All Time High

CN¥31.09